Uvadex

Uvadex is a brand name of methoxsalen, approved by the FDA in the following formulation(s):

UVADEX (methoxsalen - injectable; injection)

• 
  Manufacturer: THERAKOS
  
  Approval date: February 25, 1999
  
  Strength(s): 0.02MG/ML ^[RLD]

Has a generic version of Uvadex been approved?

No. There is currently no therapeutically equivalent version of Uvadex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Uvadex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Uvadex.

See also...

• Uvadex Advanced Consumer Information (Micromedex)
• Methoxsalen Hard-Gelatin Capsules Consumer Information (Wolters Kluwer)
• Methoxsalen Soft-Gelatin Capsules Consumer Information (Wolters Kluwer)
• Methoxsalen Consumer Information (Cerner Multum)
• Methoxsalen Advanced Consumer Information (Micromedex)
• Methoxsalen Injection Advanced Consumer Information (Micromedex)